A case of double leukemia: chronic myeloid leukemia intolerant to imatinib and chronic lymphocytic leukemia

被引:0
|
作者
Rocchi, Miriana [1 ]
机构
[1] UO Med Interna 1, Osped F Lotti, Pontedera, PI, Italy
关键词
chronic myeloid leukemia; imatinib resistance; chronic lymphocytic leukemia; nilotinib;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML) are the most common leukemias of the elderly. However, the sequential occurrence of CML followed by CLL in the same patient is extremely rare. We present a report of a 70-year-old man who developed CLL six years after the diagnosis of CML in molecular, cytogenetic and morphologic remission. The diagnosis of CLL is confirmed by peripheral lymphocytosis. The first line therapy in CML in chronic phase is still imatinib, but in the present case the patient was intolerant to imatinib, therefore he switched to nilotinib after few months.
引用
下载
收藏
页码:13 / 16
页数:4
相关论文
共 50 条
  • [41] Treatment of chronic myeloid leukemia with imatinib mesylate
    Ohno R.
    International Journal of Clinical Oncology, 2006, 11 (3) : 176 - 183
  • [43] Imatinib in chronic myeloid leukemia elderly patients
    Gugliotta, Gabriele
    Castagnetti, Fausto
    Palandri, Francesca
    Baccarani, Michele
    Rosti, Gianantonio
    AGING-US, 2011, 3 (12): : 1125 - 1126
  • [44] Antituberculosis therapy and imatinib for chronic myeloid leukemia
    Sora, Federica
    De Matteis, Silvia
    Di Mario, Antonella
    Maiuro, Giuseppe
    Laurenti, Luca
    Chiusolo, Patrizia
    Ardito, Fausta
    Leone, Giuseppe
    Sica, Simona
    CLINICAL INFECTIOUS DISEASES, 2006, 43 (09) : 1223 - 1224
  • [45] Imatinib mesylate and treatment of chronic myeloid leukemia
    Yamada, Hisashi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 39P - 39P
  • [46] Sprycel for chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to or intolerant of imatinib mesylate
    Brave, Michael
    Goodman, Vicki
    Kaminskas, Edvardas
    Farrell, Ann
    Timmer, William
    Pope, Sarah
    Harapanhalli, Ravi
    Saber, Haleh
    Morse, David
    Bullock, Julie
    Men, Angela
    Noory, Carol
    Ramchandani, Roshni
    Kenna, Leslie
    Booth, Brian
    Gobburu, Joga
    Jiang, Xiaoping
    Sridhara, Rajeshwari
    Justice, Robert
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2008, 14 (02) : 352 - 359
  • [47] miRNA in chronic myeloid leukemia and imatinib response
    Dulucq, Stephanie
    Mahon, Francois Xavier
    PHARMACOGENOMICS, 2010, 11 (09) : 1201 - 1202
  • [48] Imatinib monitoring in chronic myeloid leukemia patients
    Kilic, P.
    Kayaalti, Z.
    Gunduz, M.
    Gurman, G.
    Soylemezoglu, T.
    TOXICOLOGY LETTERS, 2015, 238 (02) : S241 - S241
  • [49] DOUBLE TROUBLE: SIMULTANEOUS PRESENTATION OF CHRONIC LYMPHOCYTIC LEUKEMIA AND CHRONIC MYELOGENOUS LEUKEMIA
    Kovelamudi, Asha
    Smalligan, Roger D.
    Nadesan, Sue
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2016, 31 : S608 - S609
  • [50] Spotlight on imatinib mesylate in chronic myeloid leukemia
    Curran, MP
    Croom, KF
    Goa, KL
    BIODRUGS, 2004, 18 (03) : 207 - 210